These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 15803935
21. Pyoderma gangrenosum associated with Wegener's granulomatosis: partial response to mycophenolate mofetil. Le Hello C, Bonte I, Mora JJ, Verneuil L, Noël LH, Guillevin L. Rheumatology (Oxford); 2002 Feb; 41(2):236-7. PubMed ID: 11886982 [No Abstract] [Full Text] [Related]
22. Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent. Talhari C, Mahnke N, Ruzicka T, Megahed M. Clin Exp Dermatol; 2005 May; 30(3):297-8. PubMed ID: 15807696 [No Abstract] [Full Text] [Related]
23. Pyoderma gangrenosum in a patient with bullous systemic lupus erythematosus. Sakamoto T, Hashimoto T, Furukawa F. Eur J Dermatol; 2002 May; 12(5):485-7. PubMed ID: 12370142 [Abstract] [Full Text] [Related]
24. Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with cyclosporin and complicated by a mononeuritis. Gilmour E, Stewart DG. Br J Dermatol; 2001 Feb; 144(2):397-400. PubMed ID: 11251582 [Abstract] [Full Text] [Related]
33. Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients. Geilen CC, Arnold M, Orfanos CE. Br J Dermatol; 2001 Mar; 144(3):583-6. PubMed ID: 11260019 [Abstract] [Full Text] [Related]
34. Treatment of atopic dermatitis with mycophenolate mofetil. Grundmann-Kollmann M, Kaufmann R, Zollner TM. Br J Dermatol; 2001 Aug; 145(2):351-2. PubMed ID: 11531810 [No Abstract] [Full Text] [Related]
35. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. Hantash B, Fiorentino D. Arch Dermatol; 2006 Jan; 142(1):109-10. PubMed ID: 16415398 [No Abstract] [Full Text] [Related]
36. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus. Gammon B, Hansen C, Costner MI. J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078 [Abstract] [Full Text] [Related]
37. Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent. Li J, Kelly R. J Am Acad Dermatol; 2013 Oct; 69(4):565-9. PubMed ID: 23850090 [Abstract] [Full Text] [Related]
38. Mycophenolate mofetil and systemic lupus erythematosus: an overview. Pisoni CN, Karim Y, Cuadrado MJ. Lupus; 2005 Oct; 14 Suppl 1():s9-11. PubMed ID: 15803925 [Abstract] [Full Text] [Related]
39. Change of treatment from cyclosporin to mycophenolate mofetil in severe psoriasis. Davison SC, Morris-Jones R, Powles AV, Fry L. Br J Dermatol; 2000 Aug; 143(2):405-7. PubMed ID: 10951153 [Abstract] [Full Text] [Related]